Merck

RECARBRIO

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Merck

Recarbrio HCPCS:

J0742

HCPCS Code Descriptor:

Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg

Category:

J Code

Recarbrio NDCs:

00006-3856-02

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Recarbrio CPT Codes:

Potential CPT administration codes for Recarbrio can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00006-3856-02

About Recarbrio:

RECARBRIO is an Antibiotic drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J0742 is aligned to the drug RECARBRIO.

ACCESS PRICING AND MORE BY REGISTERING

J0742 Added Date:

July 1, 2020

J0742 Effective Date:

July 1, 2020

J0742 Termination Date:

HCPCS Active

Recarbrio billing and coding information can be found through Merck at the link below:
Recarbrio patient assistance information can be found through The Merck Helps Program at the URL: https://www.merckhelps.com/
RECARBRIO prescribing information can be found at the link below:
Information regarding RECARBRIO’s side effects can be found at MedlinePlus